advertisement
Xu L 19
Showing records 1 to 19 | Display all abstracts from Xu L72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Chen S
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Xu L
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Lv J
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Zhang Y; Guo R
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Fan S
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Shen W
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Zhang H
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Qi Y
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Xie L
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Wang Q
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Xu L
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Guo Z
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Jiang B; Yuan H
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Qi C
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Liang Y
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Yin H
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Li S
Trials 2017; 18: 130
72879 HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress
Wang J
Oncotarget 2017; 8: 21818-21833
72661 Laser peripheral iridotomy versus laser peripheral iridotomy plus laser peripheral iridoplasty in the treatment of multi-mechanism angle closure: study protocol for a randomized controlled trial
Chen P; Zhang X; Wang N;
Trials 2017; 18: 130
